MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Hereditary spastic paraparesis due to SPG11 gene mutation presenting as dopa responsive dystonia

    P. Chatterpal, F. Mustafa, D. Mr, AK. Srivastava, K. Sai Krishna (NEW DELHI, India)

    Objective: To describe a case of HSP presenting as spastic paraparesis with extrapyramidal features Background: Hereditary spastic paraparesis is a heterogeneous group of neurodegenerative disorders…
  • 2023 International Congress

    3D-accelerometry characteristics of essential tremor and dystonic tremor

    T. Tsuboi, K. Sawada, S. Hoshino, M. Higuchi, M. Mutho, Y. Ito, D. Nakatsubo, T. Ishizaki, T. Tanei, S. Maesawa, M. Sato, D. Tamakoshi, T. Uematsu, K. Hiraga, Y. Satake, M. Suzuki, R. Saito, M. Katsuno (Nagoya Shi, Japan)

    Objective: We aimed to characterize essential tremor and dystonic tremor using 3D accelerometry analysis. Background: Diagnosing essential tremor (ET) and dystonic tremor (DT) is often challenging.…
  • 2023 International Congress

    Outcomes From Genetic Testing in a UK Movement Disorder Clinic

    H. Morrison, L. Leemet, I. Berry, M. Boca (Bristol, United Kingdom)

    Objective: The reported yield from next generation sequencing (NGS) in Movement Disorder clinics is 11.3 – 22% [1,2]. We aimed to determine current practice and yield…
  • 2023 International Congress

    An international consensus statement for rehabilitation care in Parkinson’s disease

    J. Goldman, D. Volpe, T. Ellis, M. Hirsch, J. Johnson, J. Wood, A. Aragon, R. Biundo, A. Dirocco, G. Kasman, R. Iansek, J. Miyasaki, V. Mcconvey, M. Munneke, S. Pinto, K. St Clair, S. Toledo, M. York, R. Todaro, N. Yarab, K. Wallock (Chicago, USA)

    Objective: To develop a consensus statement regarding the incorporation of rehabilitation in Parkinson’s (PD) care. Background: As a complex, progressive disorder, PD can impact daily…
  • 2023 International Congress

    Decreased α-synuclein membrane-binding in the enteric nervous system as a marker of early pathology in Parkinson’s disease

    V. Gao, J. Briano, L. Komer, C. Crawford, C. Henchcliffe, A. Lee, J. Burré (Brooklyn, USA)

    Objective: The goal is to measure α-Synuclein (αSyn) membrane-binding in the enteric and central nervous system in Parkinson’s disease (PD) using both a novel, humanized…
  • 2023 International Congress

    Machine learning selects common fMRI features of cognitive impairment in Parkinson’s disease from cross-institution datasets

    CY. Chien, TY. Lin, TL. Lee, CCK. Lin (Tainan, Taiwan)

    Objective: To obtain common features of Parkinson's disease (PD) with cognitive impairment (CI) in resting-state functional MRI (rs-fMRI) from cross-institution datasets by adopting machine learning.…
  • 2023 International Congress

    Olfactory discrimination ability is associated with subjective lack of social support in female Parkinson’s patients

    T. Blum, L. Consortium, R. Dodel (Essen, Germany)

    Objective: We aimed to explore the relationship between olfactory discrimination ability and subjective social support in a sample of patients with Parkinson’s Disease. We hypothesized…
  • 2023 International Congress

    Tremors and More: A Case Report of TBK1 Mutation and Electrophysiological Assessment

    B. Elahi (Maywood, USA)

    Objective: TBK1 mutations have been associated with a range of neurological disorders, but their association with tremor is not well-documented. Here, we present a case…
  • 2023 International Congress

    Chronotropic incompetence – a possible marker of severe Parkinson’s disease phenotype?

    M. Andréasson, P. Svenningsson (Stockholm, Sweden)

    Objective: Perform a retrospective analysis of patients with Parkinson’s disease (PD) who previously have undergone a cardiac stress test, with the aim of comparing clinical…
  • 2023 International Congress

    The N6-Methyladenosine mRNA Methylase METTL14 Regulates TLR4-mediated intestinal dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, ZZ. Lu, L. Wei, LL. Wu, F. Yu (Guangzhou, China)

    Objective: The aim of this study is to explore the function and mechanism of RNA m6A modification in gut-derived inflammation of Parkinson's disease (PD). Background:…
  • « Previous Page
  • 1
  • …
  • 25
  • 26
  • 27
  • 28
  • 29
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley